Latest financial market updates and expert analysis
Analysis Biotechnology firm Scholar Rock is poised to make a significant strategic shift from a development-stage company to a commercial entity. The catalyst for this transition is its lead candidate, apitegromab,...
While The Trade Desk closed its last fiscal year with a solid increase in profit, the advertising technology specialist is...
Wall Street’s attention has turned to biotech firm Ocugen as it advances its gene therapy programs for inherited retinal diseases....
Pharmaceutical giant Eli Lilly is executing a simultaneous two-front strategy to solidify its commanding position in the multi-billion dollar weight-loss...
Energy giant Shell finds itself operating on two critical geopolitical fronts simultaneously. The company is currently managing supply disruptions from...
Heidelberg Materials has permanently closed its cement plant in Paderborn, Germany, marking a decisive move in response to persistent weakness...
The Australian medical technology sector is undergoing a significant reassessment, and its leading player, Cochlear, finds itself squarely in the...
In periods of bond market volatility, investors often seek strategies that can potentially generate returns regardless of the broader economic...
The British engineering services sector is presenting a complex backdrop for specialist firms like Pipehawk. While the company’s core divisions...
Barrick Gold Corporation finds itself navigating a complex landscape of robust financial health and new legal uncertainty. In early March,...
A significant realignment is underway at Puma SE, marked by the emergence of a powerful new anchor shareholder. Anta Sports,...
